Fox Chase Cancer Center News

PHILADELPHIA (November 26, 2018) – Y. Lynn Wang, MD, PhD, FCAP, is a board-certified molecular pathologist who specializes in the development and interpretation of molecular and genomic clinical assays including next-gen sequencing assays. As part of her transition, the Wang Lab was relocated to Fox Chase from the University of Chicago.

Looking back on the remarkable career of medical oncologist Paul F. Engstrom. who retires after nearly 50 years of service at Fox Chase Cancer Center

PHILADELPHIA (November 27, 2018) – Jennifer Barsky Reese, PhD,  will evaluate the efficacy of a couple-based intervention that addresses breast cancer-related sexual concerns and is delivered via telephone to post-treatment breast cancer survivors and their intimate partners in a multi-site randomized controlled trial.

PHILADELPHIA (November 26, 2018) – Camille Ragin, PhD, MPH, has received a grant from the National Institutes of Health (NIH) in the amount of $3.3 million to study cancer and cardiovascular disease risk (CVD) in Caribbean countries.

PHILADELPHIA (November 26, 2018) – Main Line Today has named Fox Chase Cancer Center East Norriton-Hospital Outpatient Center physicians in a range of specialties including, breast, surgical, gynecology, prostate, and radiation. Physicians from the region were asked to vote on top doctors from an array of specialties. 

PHILADELPHIA (November 21, 2018)— For the second time this year, Sergei Grivennikov, PhD, assistant professor in the Cancer Prevention and Control Program at Fox Chase Cancer Center, has received a R01 grant from the National Cancer Institute to support research on the connection between inflammation and colorectal cancer. The grant will provide $2.5 million over five years.

PHILADELPHIA (November 21, 2018) – The National Institutes of Health has awarded a $599,789 grant to Fox Chase Cancer Center for the purchase of a multiphoton microscopy system.

PHILADELPHIA (November 21, 2018) — Research from Fox Chase Cancer Center shows that IL-23 and IL22 cytokines modulate microbiota composition and impact diet-induced atherosclerosis.